BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 16309194)

  • 1. DNA ligase IV is a potential molecular target in ACNU sensitivity.
    Kondo N; Takahashi A; Mori E; Noda T; Su X; Ohnishi K; McKinnon PJ; Sakaki T; Nakase H; Ono K; Ohnishi T
    Cancer Sci; 2010 Aug; 101(8):1881-5. PubMed ID: 20487264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy Blocker Lonidamine Reverses Nimustine Resistance in Human Glioblastoma Cells through Energy Blockade, Redox Homeostasis Disruption, and
    Huang Y; Wang P; Fan T; Zhang N; Zhao L; Zhong R; Sun G
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1518-1532. PubMed ID: 38751635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against malignant progression of spontaneously developing liver tumors in transgenic mice expressing O(6)-methylguanine-DNA methyltransferase.
    Qin X; Zhang S; Matsukuma S; Zarkovic M; Shimizu S; Ishikawa T; Nakatsuru Y
    Jpn J Cancer Res; 2000 Nov; 91(11):1085-9. PubMed ID: 11092970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic approach to rational therapeutic doses for human tumor-bearing nude mice.
    Inaba M; Kobayashi T; Tashiro T; Sakurai Y
    Jpn J Cancer Res; 1988 Apr; 79(4):509-16. PubMed ID: 3133339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells.
    Chakkath T; Lavergne S; Fan TM; Bunick D; Dirikolu L
    Vet Sci; 2015 Apr; 2(2):52-68. PubMed ID: 29061931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroethylating anticancer drug-induced mutagenesis and its repair in
    Yamada Y; Watanabe S; Okamoto K; Arimoto S; Takahashi E; Negishi K; Negishi T
    Genes Environ; 2019; 41():11. PubMed ID: 30988834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.
    Kagohara LT; Schussel JL; Subbannayya T; Sahasrabuddhe N; Lebron C; Brait M; Maldonado L; Valle BL; Pirini F; Jahuira M; Lopez J; Letelier P; Brebi-Mieville P; Ili C; Pandey A; Chatterjee A; Sidransky D; Guerrero-Preston R
    Future Oncol; 2015; 11(2):233-49. PubMed ID: 25066711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on MGMT assay and tumor individual predictable chemotherapy].
    Zhang YP
    Ai Zheng; 2004 Jun; 23(6):724-34. PubMed ID: 15191682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene silencing in phenomena related to DNA repair.
    Mukai T; Sekiguchi M
    Oncogene; 2002 Dec; 21(58):9033-42. PubMed ID: 12483518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
    Sato K; Kitajima Y; Koga Y; Miyazaki K
    Anticancer Res; 2005; 25(6B):4021-8. PubMed ID: 16309194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.
    Sato K; Kitajima Y; Kohya N; Miyoshi A; Koga Y; Miyazaki K
    Int J Oncol; 2005 Jun; 26(6):1653-61. PubMed ID: 15870882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
    Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
    Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinoma.
    Kohya N; Miyazaki K; Matsukura S; Yakushiji H; Kitajima Y; Kitahara K; Fukuhara M; Nakabeppu Y; Sekiguchi M
    Ann Surg Oncol; 2002 May; 9(4):371-9. PubMed ID: 11986189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of O6-methylguanine-DNA methyltransferase-mediated 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea resistance by O6-benzylguanine in vitro and in vivo.
    Chen JM; Zhang YP; Sui JL; Moschel RC; Ikenaga M
    Anticancer Res; 1993; 13(3):801-5. PubMed ID: 8317915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different initial steps of apoptosis induced by two types of antineoplastic drugs.
    Takagi Y; Hidaka M; Sanada M; Yoshida H; Sekiguchi M
    Biochem Pharmacol; 2008 Aug; 76(3):303-11. PubMed ID: 18573489
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.